Table 1. Patient clinical features and miR-410 expression profile.

Pat. No.	Gender	Age	Differentiation	Metastatic or non-metastatic	Histological grade	Clinical stage	Relative miR-410 Expression
1	M	67	Low	N	S	IA	1.36
2	M	51	Medium	N	A	IIA	0.61
3	F	40	Low	Y	S	IA	0.53
4	M	53	Low	Y	A	IIIA	0.71
5	M	65	Medium	N	S	IB	2.21
6	F	70	Low	Y	A	IA	0.47
7	F	56	Medium	N	A	IB	2.57
8	M	57	Low	Y	A	IIA	1.66
9	M	47	Medium	Y	S	IIA	0.29
10	F	50	Low	Y	S	IA	12.43
11	M	64	Low	N	A	IB	0.23
12	M	63	Low	N	S	IV	3.49
13	M	57	Low	N	A	IB	1.30
14	M	61	Low	Y	S	IV	1.95
15	M	67	Low	N	A	IA	0.19
16	M	69	Medium	N	S	IA	1.37
17	M	51	Low	Y	A	IIA	0.33
18	M	58	Medium	N	S	IIA	0.26
19	M	69	Low	N	S	IA	1.11
20	F	60	Medium	N	A	IA	1.48
21	M	57	Low	N	S	IB	0.51
22	F	48	Medium	N	A	IB	3.28
23	F	61	Low	Y	A	IIIA	1.58
24	M	57	Low	Y	A	IV	1.41
25	F	73	Medium	N	A	IV	0.044
26	F	52	Medium	N	A	IA	0.58
27	M	59	Medium	N	S	IA	0.24
28	M	52	Low	Y	S	IIB	1.99
29	M	53	Medium	Y	A	IIB	0.56
30	M	63	Medium	N	A	IA	2.7
31	M	66	Low	Y	A	IIA	2.64
32	F	68	Medium	Y	A	IIB	0.57
33	M	73	Low	Y	A	IIB	1.56
34	F	50	Medium	Y	A	IIA	1.35
35	F	41	Medium	N	A	IIA	0.3
36	F	63	Medium	N	A	IA	0.34

Note: M, male; F, female; A, adenocarcinoma; S, squamous cell carcinoma; L, large cell carcinoma; Y, yes; N, no. Relative expression of miR-410 was performed by the 2^−ΔΔCt method with adjacent non-tumorous lung tissues as a calibrator. Data show the means from independent analyses. Every independent analysis by Real - time PCR was carried out immediately after the RNA extraction and reverse transcribed. ΔCt obtained from real-time PCR was subjected to paired t-test (ΔCt = Ct_miR-410−Ct_U6).